Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1395 CLN 619 a clinical stage MICA B specific IgG1 antibody which restores the MICA B-NKG2D axis requires Fc function for potent anti-tumor activity
Compose a Response to This Article
Other responses
No responses have been published for this article.